Roche has shared positive new 96-week data for its investigational fenebrutinib in patients with relapsing forms of multiple ...

The Committee for Medicinal Products for Human Use (CHMP) has recommended that Imfinzi be used in combination with ...

‘Rise Up’ features UK spoken word poet and hip-hop artist Duke Al Durham, who also has aT1D, and is inspired by the artists’ ...

A team of researchers from the UK Dementia Research Institute (UKDRI) are evaluating whether a new blood test can ...

It will be a long storm to weather, but change is afoot and the future is bright Now more than ever, the sector needs bold, ...

Sustainable health cannot be solved by science, clinical trial representation and access alone. It’s also down to how we live ...

Biogen and City Therapeutics have announced a partnership worth over $1bn to develop new RNAi therapies. The collaboration ...

Sanofi has announced that it will be acquiring Vigil Neuroscience and its investigational Alzheimer’s disease (AD) drug for ...

These groundbreaking treatments offer new hope for patients to live longer and healthier lives. But ensuring patients benefit ...

Johnson & Johnson (J&J) has announced that a US Food and Drug Administration (FDA) panel of experts has recommended Darzalex ...

Merck & Co – known as MSD outside the US and Canada – has shared promising results from a late-stage study of its anti-PD-1 ...

This sounds entirely obvious but failure to translate this insight into more innovative patient support contributes to the ...